Swedish Medical Products Agency updates Galderma's license for liquid botulinum toxin A production and testing.
Swedish Medical Products Agency granted Galderma key license updates to manufacture and test its proprietary liquid botulinum toxin A, RelabotulinumtoxinA. This supports Galderma's expansion of its Uppsala facility in Sweden, a world-class center of excellence, to meet the global demand for premium dermatology solutions. The license updates enable the company to pursue new growth and innovation strategies.
June 19, 2024
4 Articles